These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 16273227

  • 1. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma.
    Lagerstedt KK, Kressner U, Lönnroth C, Nordgren S, Lundholm K.
    Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227
    [Abstract] [Full Text] [Related]

  • 2. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T, Takahashi H, Habano W, Nakamura S, Sato K, Orii S, Suzuki K.
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [Abstract] [Full Text] [Related]

  • 3. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC, Lin JK, Lin TC, Liang WY.
    Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
    [Abstract] [Full Text] [Related]

  • 4. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A, Kressner U, Lönnroth C, Andersson M, Lindmark G, Lundholm K.
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [Abstract] [Full Text] [Related]

  • 5. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
    Arribas R, Ribas M, Risques RA, Masramon L, Tórtola S, Marcuello E, Aiza G, Miró R, Capellà G, Peinado MA.
    Clin Cancer Res; 1999 Nov; 5(11):3454-9. PubMed ID: 10589758
    [Abstract] [Full Text] [Related]

  • 6. SMAD4 as a prognostic marker in colorectal cancer.
    Alazzouzi H, Alhopuro P, Salovaara R, Sammalkorpi H, Järvinen H, Mecklin JP, Hemminki A, Schwartz S, Aaltonen LA, Arango D.
    Clin Cancer Res; 2005 Apr 01; 11(7):2606-11. PubMed ID: 15814640
    [Abstract] [Full Text] [Related]

  • 7. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
    Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, Salovaara R, Nicorici D, Hautaniemi S, Alazzouzi H, Mecklin JP, Järvinen H, Hemminki A, Astola J, Schwartz S, Aaltonen LA.
    Gastroenterology; 2005 Sep 01; 129(3):874-84. PubMed ID: 16143127
    [Abstract] [Full Text] [Related]

  • 8. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.
    Elsaleh H, Powell B, McCaul K, Grieu F, Grant R, Joseph D, Iacopetta B.
    Clin Cancer Res; 2001 May 01; 7(5):1343-9. PubMed ID: 11350904
    [Abstract] [Full Text] [Related]

  • 9. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
    Götte K, Riedel F, Neubauer J, Schäfer C, Coy JF, Hörmann K.
    Int J Oncol; 2001 Aug 01; 19(2):331-6. PubMed ID: 11445847
    [Abstract] [Full Text] [Related]

  • 10. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
    Yang Y, Forslund A, Remotti H, Lönnroth C, Andersson M, Brevinge H, Svanberg E, Lindnér P, Hafström L, Naredi P, Lundholm K.
    Cancer; 2001 Feb 15; 91(4):727-36. PubMed ID: 11241240
    [Abstract] [Full Text] [Related]

  • 11. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma.
    Lindforss U, Fredholm H, Papadogiannakis N, Gad A, Zetterquist H, Olivecrona H.
    Cancer; 2000 Jun 15; 88(12):2661-7. PubMed ID: 10870047
    [Abstract] [Full Text] [Related]

  • 12. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma.
    Kahlenberg MS, Stoler DL, Rodriguez-Bigas MA, Weber TK, Driscoll DL, Anderson GR, Petrelli NJ.
    Cancer; 2000 Apr 15; 88(8):1814-9. PubMed ID: 10760757
    [Abstract] [Full Text] [Related]

  • 13. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
    de Jong KP, Gouw AS, Peeters PM, Bulthuis M, Menkema L, Porte RJ, Slooff MJ, van Goor H, van den Berg A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4067-73. PubMed ID: 15930341
    [Abstract] [Full Text] [Related]

  • 14. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver.
    Lamb RF, Going JJ, Pickford I, Birnie GD.
    Cancer Res; 1996 Feb 15; 56(4):916-20. PubMed ID: 8631033
    [Abstract] [Full Text] [Related]

  • 15. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
    Ott K, Vogelsang H, Mueller J, Becker K, Müller M, Fink U, Siewert JR, Höfler H, Keller G.
    Clin Cancer Res; 2003 Jun 15; 9(6):2307-15. PubMed ID: 12796400
    [Abstract] [Full Text] [Related]

  • 16. Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumors with high-frequency microsatellite instability.
    Fernández-Peralta AM, Nejda N, Oliart S, Medina V, Azcoita MM, González-Aguilera JJ.
    Cancer Genet Cytogenet; 2005 Feb 15; 157(1):18-24. PubMed ID: 15676142
    [Abstract] [Full Text] [Related]

  • 17. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.
    Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N, TP53-CRC Collaborative Study Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7518-28. PubMed ID: 16172461
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M, Ataizi-Celikel C, Düşünceli F, Sönmez O, Gulluoglu BM, Sav A, Ozer A.
    J Gastrointestin Liver Dis; 2007 Mar 20; 16(1):11-7. PubMed ID: 17410283
    [Abstract] [Full Text] [Related]

  • 19. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L, Bottarelli L, Bader G, Iusco D, Pizzi S, Costi R, D'Adda T, Bertolani M, Roncoroni L, Bordi C.
    Dis Colon Rectum; 2004 Sep 20; 47(9):1467-82. PubMed ID: 15486743
    [Abstract] [Full Text] [Related]

  • 20. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T, Curia MC, Aceto G, Verginelli F, Cascinu S, Cama A, Mariani-Costantini R, Teti D, Battista P.
    Oncol Rep; 2005 Sep 20; 14(3):625-31. PubMed ID: 16077965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.